Literature DB >> 6970099

Increase of peripheral B lymphocytes in Graves' disease.

H Mori, N Amino, Y Iwatani, O Kabutomori, S Asari, S Motoi, K Miyai, Y Kumahara.   

Abstract

Peripheral T and B lymphocytes were examined in autoimmune thyroid diseases. The percentages of T and B lymphocytes were calculated from the proportions of E and EAC rosette-forming cells and peroxidase-positive cells determined by micromethods. In thyrotoxic Graves' disease, the percentage of T cells was significantly lower, and the percentage of B cells was higher than in normal controls. The absolute count of B lymphocytes was also markedly increased. The serum levels of thyroid hormones showed a significant correlation with the percentage of B cells and an inverse correlation with that of T cells in untreated cases of Graves' disease. Similar abnormalities of lymphocyte subpopulations were observed in patients with thyrotoxic Graves' disease under drug therapy, but the proportions and absolute counts of T and B lymphocytes were normal in euthyroid patients with Graves' disease, either under drug therapy or in remission. No abnormalities in T and B cells were found in Hashimoto's disease. The data indicate that the main feature of the abnormality of the lymphocyte subpopulations in thyrotoxic Graves' disease is an increase of B lymphocytes. The reasons for the discrepancy between our results and those of earlier reports and for the B cell abnormality in Graves' disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970099      PMCID: PMC1537063     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Human lymphocyte subpopulations. Effect of corticosteroids.

Authors:  D T Yu; P J Clements; H E Paulus; J B Peter; J Levy; E V Barnett
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  The effect of thyroid antigens on the in vitro migration of leucocytes from patients with Hashimoto thyroiditis.

Authors:  E A Calder; D McLeman; E W Barnes; W J Irvine
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

3.  Leucocyte migration inhibition in thyroid disease. Effect of human thyroid microsomes and thyroglobulin.

Authors:  J Wartenberg; D Doniach; J Brostoff; I M Roitt
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

4.  Thymus-derived rosette-forming cells.

Authors:  J Wybran; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-05-17       Impact factor: 91.245

5.  Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis.

Authors:  N R Farid; R E Munro; V V Row; R Volpé
Journal:  N Engl J Med       Date:  1973-06-21       Impact factor: 91.245

6.  Increase of T cells in Graves' disease.

Authors:  N Aoki; G Wakisaka; I Nagata
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

7.  Lymphocyte transformation with thyroglobulin in thyroid diseases.

Authors:  G Delespesse; J Duchateau; H Collet; A Govaerts; P A Bastenie
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

8.  Hyperthyroidism and cortisol secretion in man.

Authors:  T F Gallagher; L Hellman; J Finkelstein; K Yoshida; E D Weitzman; H D Roffwarg; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1972-06       Impact factor: 5.958

9.  Cytotoxic lymphocytes in Hashimoto's thyroiditis.

Authors:  W K Podleski
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

10.  Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).

Authors:  L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

View more
  8 in total

Review 1.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Marked increase of CD5 + B cells in hyperthyroid Graves' disease.

Authors:  Y Iwatani; N Amino; T Kaneda; K Ichihara; H Tamaki; J Tachi; F Matsuzuka; S Fukata; K Kuma; K Miyai
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.

Authors:  B Pautard; J J Rémy; J Charreire
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

4.  Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.

Authors:  C Fournier; H Chen; A Leger; J Charreire
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

5.  Decrease of peripheral large granular lymphocytes in Graves' disease.

Authors:  Y Iwatani; N Amino; O Kabutomori; H Mori; H Tamaki; S Motoi; Y Izumiguchi; K Miyai
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Authors:  K Van der Weerd; P M Van Hagen; B Schrijver; D J Kwekkeboom; W W De Herder; M R J Ten Broek; P T E Postema; J J M Van Dongen; F J T Staal; W A Dik
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

7.  Microarray profile of B cells from Graves' disease patients reveals biomarkers of proliferation.

Authors:  Xuechao Jiang; Yonghui Wang; Xiaoying Li; Leqi He; Qian Yang; Wei Wang; Jun Liu; Bingbing Zha
Journal:  Endocr Connect       Date:  2020-05-01       Impact factor: 3.335

8.  Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes.

Authors:  Linda Yip; Rebecca Fuhlbrigge; Reem Alkhataybeh; C Garrison Fathman
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-23       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.